ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,098.58
0.83%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.955
-0.01%
Brent Oil
81.965
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NYSE
  6. Charles River Laboratories International Inc (CRL)

  7. Charles River Laboratories International Inc (CRL) ニュース

CRL

Charles River Laboratories (CRL)

Charles River Laboratories International Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:CRL
日付受信時刻ニュースソース見出しコード企業名
2024/05/1705 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1608 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1608 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1606 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1606 : 47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1606 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1606 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1606 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1606 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1606 : 27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1606 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1605 : 06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1505 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1105 : 07Edgar (US Regulatory)Form 8-K - Current reportNYSE:CRLCharles River Laboratories International Inc
2024/05/1100 : 30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
2024/05/1005 : 20Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:CRLCharles River Laboratories International Inc
2024/05/0922 : 17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CRLCharles River Laboratories International Inc
2024/05/0920 : 31Edgar (US Regulatory)Form 8-K - Current reportNYSE:CRLCharles River Laboratories International Inc
2024/05/0920 : 00Business WireCharles River Laboratories Announces First-Quarter 2024 ResultsNYSE:CRLCharles River Laboratories International Inc
2024/05/0221 : 00Business WireCharles River Launches Viral Vector Reference Materials to Streamline the Transition to GMPNYSE:CRLCharles River Laboratories International Inc
2024/04/2221 : 00Business WireCharles River Laboratories Achieves 100% Renewable Electricity Usage GloballyNYSE:CRLCharles River Laboratories International Inc
2024/04/1621 : 00Business WireCharles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal TestingNYSE:CRLCharles River Laboratories International Inc
2024/04/1221 : 00Business WireCharles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference CallNYSE:CRLCharles River Laboratories International Inc
2024/04/1121 : 00Business WireCharles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic PathologyNYSE:CRLCharles River Laboratories International Inc
2024/04/0921 : 00Business WireCharles River Announces Rare Disease Gene Therapy Collaboration with Axovia TherapeuticsNYSE:CRLCharles River Laboratories International Inc
2024/04/0421 : 00Business WireCharles River to Perform Plasmid Production for Ship of TheseusNYSE:CRLCharles River Laboratories International Inc
2024/04/0421 : 00Business WireCharles River to Perform Plasmid Production for Ship of TheseusNYSE:CRLCharles River Laboratories International Inc
2024/04/0121 : 00Business WireCharles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024NYSE:CRLCharles River Laboratories International Inc
2024/03/2721 : 00Business WireCharles River Laboratories Publishes 2023 Corporate Citizenship ReportNYSE:CRLCharles River Laboratories International Inc
2024/03/2121 : 00Business WireCharles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of MedicineNYSE:CRLCharles River Laboratories International Inc
 Showing the most relevant articles for your search:NYSE:CRL

最近閲覧した銘柄

FX
USDEUR
US Dollar vs Euro
NASDAQ
GOOGL
Alphabet
NYSE
KO
Coca Cola
AMEX
SPY
SPDR S&P 500
NYSE
XOM
Exxon Mobil
CCOM
US500
US 500
AMEX
XLE
Energy Select Sector SPDR
NYSE
NKE
Nike
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
NASDAQ
AAPL
Apple
USI
USTECH100
US Tech 100
USOTC
BNPQY
BNP Paribas (QX)
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有